Glucose-induced cAMP elevation in β-cells involves amplification of constitutive and glucagon-activated GLP-1 receptor signalling

被引:15
作者
Shuai, Hongyan [1 ,2 ]
Xu, Yunjian [2 ]
Ahooghalandari, Parvin [2 ]
Tengholm, Anders [2 ]
机构
[1] Dali Univ, Sch Basic Med Sci, Dali, Yunnan, Peoples R China
[2] Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
adenylyl cyclase; exendin-(9-39); glucagon; glucagon-like peptide-1; insulin secretion; pancreatic islets; INSULIN-SECRETION; CYCLIC-AMP; ADENYLYL-CYCLASE; PANCREATIC-ISLETS; ADENOSINE-3'; 5'-MONOPHOSPHATE LEVELS; PEPTIDE-1; RECEPTOR; OSCILLATIONS; EXPRESSION; CA2+; EXENDIN-(9-39);
D O I
10.1111/apha.13611
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Aim: cAMP typically signals downstream of G(s)-coupled receptors and regulates numerous cell functions. In beta-cells, cAMP amplifies Ca2+-triggered exocytosis of insulin granules. Glucose-induced insulin secretion is associated with Ca2+- and metabolism-dependent increases of the sub-plasma-membrane cAMP concentration ([cAMP](pm)) in beta-cells, but potential links to canonical receptor signalling are unclear. The aim of this study was to clarify the role of glucagon-like peptide-1 receptors (GLP1Rs) for glucose-induced cAMP signalling in beta-cells. Methods: Total internal reflection microscopy and fluorescent reporters were used to monitor changes in cAMP, Ca2+ and ATP concentrations as well as insulin secretion in MIN6 cells and mouse and human beta-cells. Insulin release from mouse and human islets was also measured with ELISA. Results: The GLP1R antagonist exendin-(9-39) (ex-9) prevented both GLP1- and glucagon-induced elevations of [cAMP](pm), consistent with GLP1Rs being involved in the action of glucagon. This conclusion was supported by lack of unspecific effects of the antagonist in a reporter cell-line. Ex-9 also suppressed IBMX- and glucose-induced [cAMP](pm) elevations. Depolarization with K+ triggered Ca2+-dependent [cAMP](pm) elevation, an effect that was amplified by high glucose. Ex-9 inhibited both the Ca2+ and glucose-metabolism-dependent actions on [cAMP](pm). The drug remained effective after minimizing paracrine signalling by dispersing the islets and it reduced basal [cAMP](pm) in a cell-line heterologously expressing GLP1Rs, indicating that there is constitutive GLP1R signalling. The ex-9-induced reduction of [cAMP](pm) in glucose-stimulated beta-cells was paralleled by suppression of insulin secretion. Conclusion: Agonist-independent and glucagon-stimulated GLP1R signalling in beta-cells contributes to basal and glucose-induced cAMP production and insulin secretion.
引用
收藏
页数:15
相关论文
共 58 条
[1]   Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats - A defect ameliorated by cAMP [J].
AbdelHalim, SM ;
Guenifi, A ;
Khan, A ;
Larsson, O ;
Berggren, PO ;
Ostenson, CG ;
Efendic, S .
DIABETES, 1996, 45 (07) :934-940
[2]   Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes [J].
Ahren, Bo .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) :369-385
[3]   The GIP Receptor Displays Higher Basal Activity than the GLP-1 Receptor but Does Not Recruit GRK2 or Arrestin3 Effectively [J].
Al-Sabah, Suleiman ;
Al-Fulaij, Munya ;
Shaaban, Ghina ;
Ahmed, Hanadi A. ;
Mann, Rosalind J. ;
Donnelly, Dan ;
Buenemann, Moritz ;
Krasel, Cornelius .
PLOS ONE, 2014, 9 (09)
[4]   Localization of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells [J].
Augstein, Petra ;
Naselli, Gaetano ;
Loudovaris, Thomas ;
Hawthorne, Wayne J. ;
Campbell, Peter ;
Bandala-Sanchez, Esther ;
Rogers, Kelly ;
Heinke, Peter ;
Thomas, Helen E. ;
Kay, Thomas W. ;
Harrison, Leonard C. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 110 (03) :291-300
[5]   Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action [J].
Campbell, Jonathan E. ;
Drucker, Daniel J. .
CELL METABOLISM, 2013, 17 (06) :819-837
[6]   β Cell tone is defined by proglucagon peptides through cAMP signaling [J].
Capozzi, Megan E. ;
Svendsen, Berit ;
Encisco, Sara E. ;
Lewandowski, Sophie L. ;
Martin, Mackenzie D. ;
Lin, Haopeng ;
Jaffe, Justin L. ;
Coch, Reilly W. ;
Haldeman, Jonathan M. ;
MacDonald, Patrick E. ;
Merrins, Matthew J. ;
D'Alessio, David A. ;
Campbell, Jonathan E. .
JCI INSIGHT, 2019, 4 (05)
[7]  
CHARLES MA, 1975, J BIOL CHEM, V250, P6134
[8]   Constitutive receptor systems for drug discovery [J].
Chen, G ;
Jayawickreme, C ;
Way, J ;
Armour, S ;
Queen, K ;
Watson, C ;
Ignar, D ;
Chen, WJ ;
Kenakin, T .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1999, 42 (04) :199-206
[9]   Decreased glucose-induced cAMP and insulin release in islets of diabetic rats: Reversal by IBMX, glucagon, GIP [J].
Dachicourt, N ;
Serradas, P ;
Giroix, MH ;
Gangnerau, MN ;
Portha, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 271 (04) :E725-E732
[10]   Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic β-cells and inhibiting insulin secretion [J].
De Leon, Diva D. ;
Li, Changhong ;
Delson, Madeleine I. ;
Matschinsky, Franz M. ;
Stanley, Charles A. ;
Stoffers, Doris A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (38) :25786-25793